Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Caffeine rushes to $113m series D
The livestreaming broadcaster was valued at more than $600m in a round co-led by investors including Cox Enterprises and Fox Corporation.
Annexon adds $100m
The round pushed the overall funding for the Novartis-backed autoimmune and neurodegenerative disorder drug developer past $250m.
Coty cuts off $200m for KKW investment
The beauty and cosmetics group is acquiring a 20% stake in Kim Kardashian West's beauty brand at a $1bn valuation in connection with a partnership agreement.
CapitalBio Technology cashes $113m
Sinopec Capital and Meinian Onehealth both invested in the biotech research product maker as it prepares for an initial public offering.
Goldfinch Bio holds on to $100m
Existing backer Gilead Sciences returned for a series B round that boosted the kidney disease therapy developer's total funding to $160m.
Discord discovers another $100m
Index Ventures participated in a round that valued the WarnerMedia and Tencent-backed communication platform developer at $3.5bn.
Xingsheng Youxuan goes shopping for $300m
Tencent has reportedly committed to a series C round set to triple grocery delivery platform Xingsheng Youxuan's valuation to $3bn.
Novo gets in Freeline for $120m round
The pharmaceutical company co-led a series C round for AAV gene therapy developer Freeline that took its total funding to $275m.

Other News

Oscar hosts Alphabet in $225m round
The health insurance provider pushed its overall funding past $1.5bn in a late-stage round that included long-term investor Alphabet.
Salesforce takes nine-figure amount to Tanium
The endpoint management software provider has secured roughly $120m from strategic partner Salesforce, bumping its valuation up from $6.5bn to $9bn.
Poseida slots in $110m ahead of IPO
Novartis and Transposagen-backed gene and cell therapy developer Poseida Therapeutics closed the series D round two days after filing to go public.
Lennar books room in Sonder's $170m series E
The short-term apartment provider raised the funding at a $1.3bn valuation and is seeking another $30m to close the round at $200m.
Pionyr maps out $1.47bn Gilead deal
Gilead Sciences will invest $275m in return for a 49.9% stake as part of a deal that could see it purchase the cancer immunotherapy developer outright.
DispatchHealth posts series C details
The home care provider has closed a round led by Optum Ventures and backed by Humana and Echo Health Ventures at approximately $136m.

Editor's Picks

Instacart collects $225m at bumper valuation
The shopping delivery app developer, which counts Comcast, American Express and Amazon among its investors, boosted its valuation to $13.7bn in the round.
Magic Leap conjures up $350m
Undisclosed new and existing investors are pumping $350m into the corporate-backed augmented reality technology developer as it prepares to cut headcount.
Stash produces $112m series F payoff
The investment and financial advice app developer raised the money at an $800m valuation, in a round led by $80m from LendingTree.
Cohesity collects $250m in series E round
HPE, Cisco Investments and SoftBank Vision Fund chipped in as the data management platform developer more than doubled its valuation to $2.5bn.
test reg